Stocksigma LogoStocksigma Logo

Aristo Bio-Tech Reports H1 FY27 Results with PAT Growth to Rs 4.90 Crore

Aristo Bio-Tech and Lifescience Limited reported standalone revenue from operations of Rs 198.24 crore for the half-year ended 30th Sep'26, down 22.7% YoY

Aristo Bio-Tech Reports H1 FY27 Results with PAT Growth to Rs 4.90 Crore

Aristo Bio-Tech & Lifescience Ltd 路 Outcome 路 15 Nov 2026, 2:24 am

Aristo Bio-Tech Reports H1 FY27 Results with PAT Growth to Rs 4.90 Crore Aristo Bio-Tech and Lifescience Limited reported standalone revenue from operations of Rs 198.24 crore for the half-year ended 30th Sep'26, down 22.7% YoY compared to Rs 256.45 crore in the corresponding period ended 30th Sep'25. Net profit rose 17.6% YoY to Rs 4.90 crore from Rs 4.17 crore, driven by lower material costs. Profit before tax stood at Rs 6.60 crore versus Rs 5.54 crore. Basic and diluted EPS improved to Rs 7.20 from Rs 6.12 YoY. Net operating cash flow was Rs 2.42 crore.

Original exchange filing (PDF)

More announcements from Aristo Bio-Tech & Lifescience Ltd

All Aristo Bio-Tech & Lifescience Ltd announcements